1 completed, 1 terminated. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Terminated 1 |
Follow entinostat: new trials by email Literature Review of entinostat trials Research Report on entinostat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC Entinostat - Breast Cancer, Invasive Breast Cancer | Early Phase 1 | Terminated | UNC Lineberger Comprehensive Cancer Center | 5 | 2018-11-28 | 2024-03-25 |
| Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer Entinostat, Hysterectomy, Laboratory Biomarker Analysis - FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | Early Phase 1 | Completed | National Cancer Institute (NCI) | 50 | 2017-10-11 | 2021-11-16 |
Breast Neoplasms (1) · Triple Negative Breast Neoplasms (1)
National Cancer Institute (NCI) (1) · UNC Lineberger Comprehensive Cancer Center (1)
United States (2)
Linda R Duska (1) · Lisa Carey, MD (1)
P50CA058223 (1), U10CA180868 (1)